Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

ALSUntangled does not support bee venom use outside a study

Original source

Bee VenomALSUntangled · 24 October 2011 (opens in a new tab)

ALSUntangled concluded that bee venom should not be used by people with ALS outside a research study. Two animal studies reported possible effects on motor preservation and inflammation, and one reported improved survival, but the studies had major methodological weaknesses. The review found very little human evidence in ALS.

Why this matters

This does not establish that bee venom benefits people with ALS or change treatment options. The review says future research would need independent replication and a dose that could realistically be used in humans, while noting that bee venom exposure can carry serious risks, including death.

Limitations and context

This is an independent expert review published in 2011, not a new clinical trial. The animal studies were small and lacked several standard safeguards, including clear randomization, blinding and power calculations. Human evidence consisted of two anecdotal, unverified reports, and the review noted that the animal dosing might not be feasible in humans.

Summarised by Compass 10 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?